Literature DB >> 3763162

Ocular Munchausen's syndrome.

P N Rosenberg, G B Krohel, R M Webb, R S Hepler.   

Abstract

Patients with contrived histories and/or self-induced physical abnormalities (Munchausen's syndrome) are often successful in deceiving physicians. We recently cared for four patients with ocular Munchausen's syndrome. Self-induced ocular manifestations included voluntary nystagmus, subconjunctival hemorrhages, chronic orbital emphysema requiring exenteration, corneal alkali burns, erosions and ulcerations, and abscesses of the periorbital area. Correct diagnoses of ocular Munchausen's syndrome were made only after extensive medical and surgical investigations. Suggestions for evaluation and treatment will also be discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3763162     DOI: 10.1016/s0161-6420(86)33613-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Adult periorbital fibromatosis.

Authors:  C N Smoot; G B Krohel; R S Smith
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

Review 2.  Hysterical symptoms in ophthalmology.

Authors:  M Weller; P Wiedemann
Journal:  Doc Ophthalmol       Date:  1989-09       Impact factor: 2.379

3.  Incomplete oedipism and chronic suicidality in psychotic depression with paranoid delusions related to eyes.

Authors:  Maurizio Pompili; David Lester; Roberto Tatarelli; Paolo Girardi
Journal:  Ann Gen Psychiatry       Date:  2006-11-21       Impact factor: 3.455

4.  Bilateral Glaucomatous Optic Neuropathy Caused by Eye Rubbing.

Authors:  Alfonso Savastano; Maria Cristina Savastano; Laura Carlomusto; Silvio Savastano
Journal:  Case Rep Ophthalmol       Date:  2015-09-02

5.  Gaze-Contingent Flicker Pupil Perimetry Detects Scotomas in Patients With Cerebral Visual Impairments or Glaucoma.

Authors:  Marnix Naber; Carlien Roelofzen; Alessio Fracasso; Douwe P Bergsma; Mies van Genderen; Giorgio L Porro; Serge O Dumoulin
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.